ARCHIVES

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

AACR, ASCO Members Concerned Over Ethics, Social Issues, And What To Do About Them

May 16, 1975

New Food Services Contractor Takes Over NIH Cafeterias.

July 14, 2000

U.S. Patients Use More Chemotherapy, Less Emergency Care than Canadians

May 27, 2011

Group Chairman Balk At Board’s Recommendations

February 15, 1980

RTOG: Hormone Therapy Increases Survival When Combined With Radiation Therapy

July 29, 2011

ASCO Growth Changes, Prepare Society for ‘90s

June 8, 1990